Trials / Completed
CompletedNCT02937831
RIXUBIS Drug Use-Result Survey (Japan)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- Baxalta now part of Shire · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this survey is to understand the following items observed in the actual clinical use of RIXUBIS. 1. Unexpected adverse drug reactions 2. Occurrence of adverse drug reactions in the actual clinical use 3. Factors that may affect safety and effectiveness 4. Occurrence of Factor IX (FIX) inhibitor development in patients with coagulation FIX deficiency 5. Safety and effectiveness for hemophilia B patients who received routine prophylactic therapy, on-demand therapy and perioperative therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | RIXUBIS |
Timeline
- Start date
- 2016-11-16
- Primary completion
- 2022-05-11
- Completion
- 2022-05-11
- First posted
- 2016-10-19
- Last updated
- 2024-07-22
- Results posted
- 2024-07-22
Locations
5 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02937831. Inclusion in this directory is not an endorsement.